Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Vanda Pharmaceuticals Inc. - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
VNDA
Nasdaq
8731
https://www.vandapharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Vanda Pharmaceuticals Inc.
AstraZeneca's (AZN) Ultomiris Gets FDA Nod for New Indication
- Mar 26th, 2024 1:56 pm
Spruce Biosciences (SPRB) Falls 86% in a Month: Here's Why
- Mar 21st, 2024 2:20 pm
Cybin (CYBN) Begins Phase II Study on Anxiety Drug, Stock Up
- Mar 18th, 2024 3:23 pm
J&J (JNJ) Gets FDA Panel Vote for Carvykti's Expanded Use
- Mar 18th, 2024 10:55 am
Pfizer's (PFE) Adcetris Meets Survival Goal in Lymphoma Study
- Mar 13th, 2024 1:54 pm
MindMed's (MNMD) Anxiety Drug Gets FDA Breakthrough Therapy Tag
- Mar 8th, 2024 3:46 pm
Vanda (VNDA) Falls on FDA's CRL to Hetlioz sNDA for Insomnia
- Mar 7th, 2024 3:47 pm
Chairman of Vanda Pharmaceuticals Inc (VNDA) Sells Shares
- Mar 7th, 2024 4:55 am
Nektar (NKTR) Begins Phase IIb Study Rezpeg in Alopecia Areata
- Mar 6th, 2024 5:33 pm
Vanda Pharmaceuticals Announces FDA Update for supplemental NDA for HETLIOZĀ® in the Treatment of Insomnia
- Mar 6th, 2024 12:00 pm
Nektar (NKTR) Q4 Loss Wider Than Expected, Revenue Beat
- Mar 5th, 2024 3:07 pm
Arcturus (ARCT) Stock Surges 73% in 3 Months: Here's Why
- Mar 4th, 2024 6:23 pm
Mirum's (MIRM) Q4 Earnings Lag Estimates, Revenues Beat
- Feb 29th, 2024 4:34 pm
Amicus' (FOLD) Q4 Earnings Beat, Revenues Meet Estimates
- Feb 29th, 2024 4:23 pm
Theravance's (TBPH) Q4 Earnings & Revenues Surpass Estimates
- Feb 27th, 2024 4:47 pm
Karuna's (KRTX) Q4 Loss Widens, Focus on Bristol Myers Buyout
- Feb 23rd, 2024 4:09 pm
Jim Simons Adds Vanda Pharmaceuticals to Portfolio in Recent Trade
- Feb 14th, 2024 9:22 am
Earnings Estimates Moving Higher for Vanda (VNDA): Time to Buy?
- Feb 12th, 2024 5:20 pm
News Flash: Analysts Just Made A Sizeable Upgrade To Their Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Forecasts
- Feb 10th, 2024 12:42 pm
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q4 2023 Earnings Call Transcript
- Feb 8th, 2024 2:38 pm
Scroll